JLL vs MAZE · P/E 23, rev $13.31B vs rev $20.0M
Jones Lang LaSalle Incorporated (JLL) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Latest reported MAZE revenue for 2026-06-30 was $20.0M. Net income was -$68.9M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. MAZE currently screens at market cap $525.3M.
JLL currently screens at market cap $12.12B and trailing P/E 23.0. MAZE currently screens at market cap $525.3M.
Not investment advice. Open the JLL and MAZE stock pages for the full models.
Not investment advice.